| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/02/2003 | EP1296689A2 Method of administering bisphosphonates |
| 04/02/2003 | EP1296685A1 Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 04/02/2003 | EP1296683A2 Methods of treating neutrophil-related diseases with topical anesthetics |
| 04/02/2003 | EP1296679A1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 04/02/2003 | EP1296677A2 Solid valsartan pharmaceutical compositions |
| 04/02/2003 | EP1296675A2 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 04/02/2003 | EP1296666A2 Improved thyroid hormone formulations |
| 04/02/2003 | EP1296664A2 Propofol for treatment of sepsis |
| 04/02/2003 | EP1296662A1 Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or '0-(2,6-dichloranilino)-phenyl!-ethanoic acid |
| 04/02/2003 | EP1296661A2 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 04/02/2003 | EP1296660A1 The controlled release preparation of insulin and its method |
| 04/02/2003 | EP1296659A1 Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine |
| 04/02/2003 | EP1296658A1 Use of an acetylated pre-gelled starch with a high content of amylose |
| 04/02/2003 | EP1296657A1 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 04/02/2003 | EP1296656A2 Method for preparing a composition |
| 04/02/2003 | EP1296655A1 Endoparasiticidal agents for voluntary oral ingestion by animals |
| 04/02/2003 | EP1296654A2 Use of dicalcium phosphate anhydride powder |
| 04/02/2003 | EP1296653A1 Method for formulating healthcare products with enhanced stability |
| 04/02/2003 | EP1296652A1 Topical pharmaceutical formulations and methods of treatment |
| 04/02/2003 | EP1296651A1 Method of making particles for use in a pharmaceutical composition |
| 04/02/2003 | EP1296650A2 Methods and compositions for treating pain of the mucous membrane |
| 04/02/2003 | EP1296649A2 Pharmaceutical compositions comprising an opioid analgesic |
| 04/02/2003 | EP1296648A1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/02/2003 | EP1296647A2 Polymeric micelle compositions |
| 04/02/2003 | EP1296646A2 Oral pharmaceutical compositions containing terbinafine |
| 04/02/2003 | EP1296645A2 Methods for treating inflammation-mediated conditions of the eye |
| 04/02/2003 | EP1296644A2 Systems and methods for treating a mucosal surface |
| 04/02/2003 | EP1263448A4 Maca and antler for augmenting testosterone levels |
| 04/02/2003 | EP1246627A4 Polyanhydrides with biologically active degradation products |
| 04/02/2003 | EP1211942B1 Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 04/02/2003 | EP1208100B1 Selective antagonists of a2b adenosine receptors |
| 04/02/2003 | EP1191999B1 Method of particle formation |
| 04/02/2003 | EP1146852B1 A cosmetic composition based on menthol and menthyl lactate, having little odor and being non-irritating |
| 04/02/2003 | EP1140479B1 Apparatus and method for manufacturing moulded products |
| 04/02/2003 | EP1135109B1 Method for producing solid forms of administration by melt extrusion |
| 04/02/2003 | EP1107739B1 Method for producing solid dosing forms |
| 04/02/2003 | EP1096940B1 Biocompatible and biodegradable compositions containing hyaluronic acid and the derivatives thereof for the treatment of ulcers in the digestive apparatus |
| 04/02/2003 | EP1087807B1 Medical infusion device with a source of controlled compliance |
| 04/02/2003 | EP1083886B1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 04/02/2003 | EP1011854B1 Method for producing aqueous emulsions or suspensions |
| 04/02/2003 | EP1001732B1 Shellac-containing cosmetic product |
| 04/02/2003 | EP0991403B1 Use of microparticles with adsorbed antigen to stimulate immune responses |
| 04/02/2003 | EP0988031B1 Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration |
| 04/02/2003 | EP0968006B1 Dressings |
| 04/02/2003 | EP0952822B1 Chitosan-gelatin a microparticles |
| 04/02/2003 | EP0946624B1 Biodegradable targetable microparticle delivery system |
| 04/02/2003 | EP0946146B1 Use of aqueous medicament preparations for the production of propellent gas-free aerosols |
| 04/02/2003 | EP0927053B1 Fragmented polymeric hydrogels for adhesion prevention and their preparation |
| 04/02/2003 | EP0917458B1 Lyophilized thioxanthenone antimumor agents |
| 04/02/2003 | EP0910348B1 Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/02/2003 | EP0858326B1 Non-aqueous colonic purgative formulations |
| 04/02/2003 | EP0845986B1 Pharmaceutical composition containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine for the treatment of cardiovascular diseases |
| 04/02/2003 | EP0828481B1 Oral dosage composition comprising zonula occludens toxin and a biologically active ingredient and use thereof |
| 04/02/2003 | EP0804283B1 Aqueous solvent encapsulation method and microcapsules |
| 04/02/2003 | EP0762897B1 Method of preventing aggregation of proteins/peptides upon rehydration or thawing |
| 04/02/2003 | EP0737066B1 Transdermal device containing polyvinylpyrrolidone as solubility enhancer |
| 04/02/2003 | EP0725631B1 Novel method for preparing dry pharmaceuticals capable of virtually instantaneous disintegration, and resulting pharmaceuticals |
| 04/02/2003 | CN1407978A Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 04/02/2003 | CN1407972A 4-pyrimidine-N-acyl-L-phenylalanines |
| 04/02/2003 | CN1407898A Novel topical oestroprogestational compositions with systemic effect |
| 04/02/2003 | CN1407897A DHEA composition and method |
| 04/02/2003 | CN1407894A Pharmaceutical composition |
| 04/02/2003 | CN1407891A Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
| 04/02/2003 | CN1407889A Flat medicinal preparation for transmucosal administration of oxycodon or comparable active ingredient in oral cavity, for use in pain therapy and in addiction therapy |
| 04/02/2003 | CN1407888A Film preparation for biphasic release of pharmacologically active or other substances |
| 04/02/2003 | CN1407887A Oral liquid compositions |
| 04/02/2003 | CN1407886A Multi-layer preparation in film form, consisting of hydrophilic polymers, for rapid release of active ingredients |
| 04/02/2003 | CN1407885A Histamine H2 antagonist effervescent composition |
| 04/02/2003 | CN1407884A Controlled release hydrocodone formulations |
| 04/02/2003 | CN1406645A Medicinal pad for magnetotherapy and preparing method thereof |
| 04/02/2003 | CN1406638A Method for coating antibiotic onto articles with interlinked micro-cavities, products thereby and use thereof |
| 04/02/2003 | CN1406637A Method for coating antibiotic onto articles with interlinked micro-cavities, products thereby and use thereof |
| 04/02/2003 | CN1406635A Medical adhesive composition and adhesive tapes or sheets therefrom |
| 04/02/2003 | CN1406634A Medical adhesive composition, adhesive tape therefrom and endermic absorbed adhesive tape products |
| 04/02/2003 | CN1406628A Hemostatics powder and preparation thereof |
| 04/02/2003 | CN1406627A Superfine powder of Tangniaokang against diabetic and preparing process |
| 04/02/2003 | CN1406625A Oral liquid |
| 04/02/2003 | CN1406588A Nano-propolis soliquoid preparation |
| 04/02/2003 | CN1406587A Use of activated carbon in oral medicinal preparation for hyperthyroidism |
| 04/02/2003 | CN1406584A Gel composition for killing parasites |
| 04/02/2003 | CN1406582A Anti-cancer salvithin injection |
| 04/02/2003 | CN1406581A Tablet preparation |
| 04/02/2003 | CN1406580A Super fine medicine powders and preparation thereof |
| 04/02/2003 | CN1104378C Fine cisplatin powder and process for production thereof |
| 04/02/2003 | CN1104276C Polyvinyl alcohol-based magnetic polymer particles, method for their preparation and their use |
| 04/02/2003 | CN1104256C Cyclosporin soft capsule composition |
| 04/02/2003 | CN1104249C Qihe fracture setting plaster with bone retaining liniment |
| 04/02/2003 | CN1104247C Suppository for treating cervical erosion and vaginitis |
| 04/02/2003 | CN1104240C Composition comprising amoxycillin and clavulanic acid, its preparation and use |
| 04/02/2003 | CN1104238C Enteric-coated pharmaceutical compositions of mycophenolate |
| 04/02/2003 | CN1104237C Use of omega-3 polyunsaturated acids |
| 04/02/2003 | CN1104235C Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 04/02/2003 | CN1104234C Carotenoid preparation capable of mixing with liquid and oil |
| 04/01/2003 | US6541616 Exterior membrane; nucleotide sequence; induction immunology response |
| 04/01/2003 | US6541606 Stabilized protein crystals formulations containing them and methods of making them |
| 04/01/2003 | US6541523 Methods for treating or preventing fibromyalgia using very low doses of cyclobenzaprine |
| 04/01/2003 | US6541518 Preventing pathogens in blood plasma and for enhancing the production of cryoprecipitate from plasma by adding a low molecular weight carboxylic acid or salt to the plasma, preferably trisodium citrate |
| 04/01/2003 | US6541508 Water solubility; prodrug containing polyether oligomer |
| 04/01/2003 | US6541447 Wound healing composition and method for use thereof |